Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin vs Sitagliptin Add-on to Metformin in T2D
NCT00666458Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2008
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by AstraZeneca. Started Apr 2008; status: completed.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00666458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00666458.